When WW launched a new compounded semaglutide product late last year, the stock surged, renewing hopes of growth revival.

Hims & Hers Health shows impressive operating leverage and a scalable business model, with massive growth potential from new ...

Q. I took Wegovy for a few months last fall until I was unable to find a pharmacy that could fill my prescription. They were ...

Attorney James Gourley details the many legal issues surrounding the GLP-1 drug market and offers advice to companies on how ...

As Novo Nordisk works through a period of transition in the U.S. GLP-1 drug market, sales from the company's star obesity ...

Today, companies across sectors including Tata Steel, Ather Energy, Bajaj Electricals, PVR INOX, Raymond, Siyaram Silk Mills, ...

Q. I took Wegovy for a few months last fall until I was unable to find a pharmacy that could fill my prescription. They were all out of stock.

Lauren Taylor speaks to Dr Jack Mosely, doctor and son of the late Michael Mosley, about the current weight-loss medication ...

After Handler told her friend that she was “on semaglutide,” her pal confirmed ... media scrutiny doesn’t help,” he wrote in the book. The singer called the weight-loss medication a ...

People taking Eli Lilly's obesity drug, Zepbound, lost nearly 50% more weight than those using rival Novo Nordisk's Wegovy in ...

A new clinical trial, published in the New England Journal of Medicine, revealed that semaglutide can significantly improve liver health in NASH patients. The study was led by Dr Arun Sanyal of ...